replimune.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi REPL
The prospects for Replimune Group, Inc. (REPL) are based on the market launch of unique immunotherapeutic drugs against tumors. This GURU.Markets terminal chart, illustrating EBITDA where 0.00 records a new level, confirms the risks of negative leverage during the testing phase. The scalability growth of the RP1 platform and FDA approval will be the decisive factors for commercial patient reach.
Replimune - rincian analitis lan metrik utama (REPL)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas Replimune Group, Inc.|REPL - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Replimune Group Inc|REPL - Utang perusahaan|Rasio utang marang nilai buku Replimune|REPL - Utang jangka dawa perusahaan|Utang jangka cendhak Replimune|Likuiditas kritis replimune.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
REPL - Penghasilan resik|Bathi resik mangsa ngarep Replimune Group, Inc.|REPL - Pangali P/E|Pangali mangsa ngarep rega marang bathi replimune.com|REPL - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Replimune|REPL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Replimune|REPL - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan replimune.com|REPL - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Replimune Group, Inc.
Analisis kabeh metrik perusahaan:Replimune Inc. - REPL
Absolute EBITDA measures the actual cash flow from core operations, excluding non-cash charges and tax adjustments to assess true financial stability. By analyzing absolute EBITDA trends, an investor can project the future profitability of Replimune Group, Inc. (REPL), considering the potential for low cost of goods sold during mass production of drugs based on their scalable immuno-oncology platform.
Pesaing Replimune Group, Inc. (REPL)
NantKwest (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX (januxrx.com)|RCUS: Bathi operasional EBITDA|ZYME - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tango Pharma|Bathi operasional sadurunge ngurangi amortisasi Iovance Corp (IOVA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Immatics N.V. (IMTX)|Bathi operasional sadurunge ngurangi amortisasi xencor.com XNCR|Compass Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Lyell LYEL|IPHA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PYXS (Pyxis Oncology, Inc.) - Bathi operasional sadurunge amortisasi|cgen.com (CGEN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi iobiotech.com (IOBT)|Bathi operasional sadurunge ngurangi amortisasi STRO|INKT - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi HOWL (Werewolf Therapeutics)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi IMMX|Bathi operasional EBITDA ALXO (ALX Oncology)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CUE|PDS Biotechnology Corp - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Sonnet BioTherapeutics|MAIA Biotechnology Inc (MAIA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Liminatus - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LVTX (LAVA Therapeutics NV) - Bathi operasional EBITDA|Bathi operasional EBITDA nextcure.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Leap Therapeutics, Inc. (LPTX)|INTS: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Sensei Biotherapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Theriva Corp (TOVX) - Bathi sadurunge bunga, pajak, lan amortisasi|GRTS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi KA (kinetabio.com)|NEXI: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Turnstone Biologics Corp. (TSBX)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Vaccinex, Inc|Harpoon Therapeutics Corp - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi
